Neuroscience20 (BRAIN20, SPINE20, and MENTAL20) Health Initiative: A Global Consortium Addressing the Human and Economic Burden of Brain, Spine, and Mental Disorders Through Neurotech Innovations and Policies

Abstract

Neurological disorders significantly impact the world’s economy due to their often chronic and life-threatening nature afflicting individuals which, in turn, creates a global disease burden. The Group of Twenty (G20) member nations, which represent the largest economies globally, should come together to formulate a plan on how to overcome this burden. The Neuroscience-20 (N20) initiative of the Society for Brain Mapping and Therapeutics (SBMT) is at the vanguard of this global collaboration to comprehensively raise awareness about brain, spine, and mental disorders worldwide. This paper aims to provide a comprehensive review of the various brain initiatives worldwide and highlight the need for cooperation and recommend ways to bring down costs associated with the discovery and treatment of neurological disorders. Our systematic search revealed that the cost of neurological and psychiatric disorders to the world economy by 2030 is roughly $16T. The cost to the economy of the United States is $1.5T annually and growing given the impact of COVID-19. We also discovered there is a shortfall of effective collaboration between nations and a lack of resources in developing countries. Current statistical analyses on the cost of neurological disorders to the world economy strongly suggest that there is a great need for investment in neurotechnology and innovation or fast-tracking therapeutics and diagnostics to curb these costs. During the current COVID-19 pandemic, SBMT, through this paper, intends to showcase the importance of worldwide collaborations to reduce the population’s economic and health burden, specifically regarding neurological/brain, spine, and mental disorders.

The feasibility, appropriateness, and usability of mobile neuro clinics in addressing the neurosurgical and neurological demand in Uganda

“…Neurological disorders are among the leading causes of death and disability worldwide, with over 22 million people living with these disorders and 5 million deaths attributed to them annually [ 1 , 2 ]. Access to neurological (synonymous with neurosurgical and neurological) care is disproportionately low in rural and remote settings, where healthcare barriers are prominent.…”

Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking

“…The treatment for Alzheimer’s was expected to cost between USD 159 and USD 215 billion in 2010. By 2040, these costs are expected to rise to USD 379 billion and more than USD 500 billion annually [ 4 ]. In Alzheimer’s disease, the loss of cholinergic neurons and, consequently, the lack of acetylcholine (Ach) are directly linked to cognition decline [ 5 ].…”

Efficacy of Transforaminal Endoscopic Lumbar Discectomy in Elderly Patients Over 65 Years of Age Compared to Young Adults

“…As the population ages, there is an increasing number of patients with spinal diseases and a corresponding need for spinal surgery [ 1 ]. In particular, degenerative lumbar spine diseases are on the rise, leading to a significant increase in the economic burden [ 2 , 3 ].…”

“…As the population ages, there is an increasing number of patients with spinal diseases and a corresponding need for spinal surgery. 1 In particular, degenerative lumbar spine diseases are on the rise, leading to a significant increase in the economic burden. 2,3 This trend is the inevitable result of a growing elderly pop-ulation and the gradual accumulation of age-related degenerative changes in the spine.…”